https://doi.org/10.1093/cid/ciaa1427. PMID: 32964223. PMCID: PMC8599727.

2. Brown A.O., Millett E.R.C., Quint J.K., Orihuela C.J. Cardiotoxicity during invasive pneumococcal disease. Am J Respir Crit Care Med. 2015; 191(7): 739–45.

https://doi.org/10.1164/rccm.201411-1951pp. PMID: 25629643. PMCID: PMC4407487.

3. Wagenvoort G.H.J., Sanders E.A.M., de Melker H.E. et al. Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia. Vaccine. 2017; 35(14): 1749–57.

https://doi.org/10.1016/j.vaccine.2017.02.037. PMID: 28262334.

4. Satzke C., Turner P., Virolainen-Julkunen A. et al.; WHO Pneumococcal Carriage Working Group. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: Updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013; 32(1): 165–79.

https://doi.org/10.1016/j.vaccine.2013.08.062. PMID: 24331112.

5. Родионова М.С., Баязитова Л.Т., Тюпкина О.Ф. с соавт. Анализ пневмококкового носительства у детей с острыми респираторными инфекциями. Проблемы медицинской микологии. 2023; 25(2): 169. (Rodionova M.S., Bayazitova L.T., Tyupkina O.F. et al. Analysis of pneumococcal carriage in children with acute respiratory infections. Problemy meditsinskoy mikologii = Problems in Medical Mycology. 2023; 25(2): 169 (In Russ.)). EDN: BBZNPP.

6. Соколова М.В., Коломиец Н.Д., Романова О.Н. с соавт. Распространенность пневмококковой инфекции среди госпитализированных детей (период наблюдения 2017–2022 годы). Медицинские новости. 2023; (4): 56–60. (Sokolova M.V., Kolomiets N.D., Romanova O.N. et al. Prevalence of pneumococcal infection in hospitalized children (observation period 2017–2022). Meditsinskie novosti = Medical News. 2023; (4): 56–60 (In Russ.)). EDN: FZZDRD.

7. Backhaus E., Berg S., Andersson R. et al. Epidemiology of invasive pneumococcal infections: Manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016; 16: 367.

https://doi.org/10.1186/s12879-016-1648-2. PMID: 27487784. PMCID: PMC4972955.

8. Ganaie F., Saad J.S., McGee L. et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus. mBio. 2020; 11(3): e00937-20.

https://doi.org/10.1128/mBio.00937-20. PMID: 32430472. PMCID: PMC7240158.

9. Masomian M., Ahmad Z., Gew L.T., Poh C.L. Development of next generation Streptococcus pneumoniae vaccines conferring broad protection. Vaccines. 2020; 8(1): 132.

https://doi.org/10.3390/vaccines8010132. PMID: 32192117. PMCID: PMC7157650.

10. (Touhami K.O., Sakkali H.E.B., Maaloum F. et al. Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study. Pan Afr Med J. 2019; 32: 203 (In French)).

https://doi.org/10.11604/pamj.2019.32.203.18157. PMID: 31312315. PMCID: PMC6620076.

11. Edmond K., Clark A., Korczak V.S. et al. Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis. Lancet Infect Dis. 2010; 10(5): 317–28.

https://doi.org/10.1016/S1473-3099(10)70048-7. PMID: 20417414.

12. Вакцинация против пневмококковой инфекции детей и взрослых: успехи и достижения. Педиатрическая фармакология. 2022; 19(2): 205–209. (Pneumococcal vaccination for children and adults: Advances and achievements. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2022; 19(2): 205–209 (In Russ.)).

https://doi.org/10.15690/pf.v19i2.2423. EDN: SWENFM.

13. Perier A., Puyade M., Revest M. et al. Prognosis of Streptococcus pneumoniae endocarditis in France, a multicenter observational study (2000–2015). Int J Cardiol. 2019; 288: 102–6.

https://doi.org/10.1016/j.ijcard.2019.04.048. PMID: 31056415.

14. Козлов Р.С. Пневмококки: уроки прошлого – взгляд в будущее. Смоленск: МАКМАХ. 2010; 127 c. (Kozlov R.S. Pneumococci: Lessons from the past – a look into the future. Smolensk: IACMAC. 2010; 127 pp. (In Russ.)). ISBN: 978-5-86064-012-2.

15. von Baum H., Schweiger B., Welte T. et al. How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J. 2011; 37(5): 1151–57.

https://doi.org/10.1183/09031936.00037410. PMID: 20817703.

16. Amin-Chowdhury Z., Aiano F., Mensah A. et al. Impact of the Coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome Coronavirus 2 (SARS-coV-2): Prospective national cohort study, England. Clin Infect Dis. 2021; 72(5): e65–e75.

https://doi.org/10.1093/cid/ciaa1728. PMID: 33196783. PMCID: PMC7717180.

17. Pletz M.W., von Baum H., van der Linden M. et al. The burden of pneumococcal pneumonia – experience of the German competence network CAPNETZ. Pneumologie. 2012; 66(8): 470–75.

https://doi.org/10.1055/s-0032-1310103. PMID: 22875730.

18. Лобзин Ю.В., Сидоренко С.В., Харит С.М. с соавт. Серотипы Streptococcus pneumoniae, вызывающих ведущие нозологические формы пневмококковых инфекций. Журнал инфектологии. 2013; 5(4): 36–42. (Lobzin Yu.V., Sidorenko S.V., Kharit S.M. et al. Serotypes of Streptococcus pneumoniae causing major pneumococcal infections. Zhurnal infektologii = Journal Infectology. 2013; 5(4): 36–42 (In Russ.)). EDN: RPRKPP.

19. Белошицкий Г.В., Королева И.С., Королева М.А. Серотиповый пейзаж пневмококков, выделенных при пневмококковом менингите, в Российской Федерации. Эпидемиология и вакцинопрофилактика. 2015; 14(2): 19–25. (Beloshitsky G.V., Koroleva I.S., Koroleva M.A. Landscape of serotypes pneumococcus isolate with pneumococcal meningitis in the Russian Federation. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccinal Prevention. 2015; 14(2): 19–25 (In Russ.)). EDN: TRSRCL.

20. Ramirez J.A., Wiemken T.L., Peyrani P. et al.; University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: Incidence, epidemiology, and mortality. Clin Infect Dis. 2017; 65(11): 1806–12.

https://doi.org/10.1093/cid/cix647. PMID: 29020164.

21. Bergenfelz C., Hakansson A.P. Streptococcus pneumoniae otitis media pathogenesis and how it informs our understanding of vaccine strategies. Curr Otorhinolaryngol Rep. 2017; 5(2): 115–24.

https://doi.org/10.1007/s40136-017-0152-6. PMID: 28616365. PMCID: PMC5446555.

22. Козлов Р.С., Кречикова О.И., Муравьев А.А. с соавт. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (PAPIRUS). Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия. 2013; 15(4): 246–260. (Kozlov R.S., Krechikova O.I., Muravyev A.A. et al. Incidence of community-acquired pneumonia and acute otitis media in children 0–5 years in Russia and role of S. pneumoniae or H. influenzae in the etiology of the diseases. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(4): 246–260 (In Russ.)). EDN: ROXOFV.

23. Monasta L., Ronfani L., Marchetti F. et al. Burden of disease caused by otitis media: Systematic review and global estimates. PLoS One. 2012;7(4): e36226.

https://doi.org/10.1371/journal.pone.0036226. PMID: 22558393. PMCID: PMC3340347.

24. Homøe P., Kverner K., Casey J.R. et al. Panel 1: Epidemiology and diagnosis. Otolaryngol Head Neck Surg. 2017; 156(4_suppl): S1–S21.

https://doi.org/10.1177/0194599816643510. PMID: 28372531.

25. Крамной А.И., Козлов В.С. Влияние назальных деконгестантов на двигательную активность цилиарного аппарата слизистой оболочки носа у пациентов с острым гнойным риносинуситом. Вестник оториноларингологии. 2010; (1): 67–68. (Kramnoy A.I., Kozlov V.S. Effect of nasal decongestants on locomotor activity of the ciliary apparatus of nasal mucosa in patients with acute purulent rhinosinusitis. Vestnik otorinolaringologii = Russian Bulletin of Otorhinolaryngology. 2010; (1): 67–68 (In Russ.)). EDN: OYENUJ

26. Асманов А.И., Пивнева Н.Д. Острые синуситы: современные подходы к диагностике и лечению. Практика педиатра. 2016; (4): 28–37. (Asmanov A.I., Pivneva N.D. Acute sinusitis: Modern approaches to diagnosis and treatment. Praktika pediatra = Paediatrician Practice. 2016; (4): 28–37 (In Russ.)). EDN: WWRTRR.

27. Brook I. Microbiology of sinusitis. Proc Am Thorac Soc. 2011; 8(1): 90–100.

https://doi.org/10.1513/pats.201006-038RN. PMID: 21364226.

28. Pena M.T., Preciado D., Orestes M., Choi S. Orbital complications of acute sinusitis: Changes in the post-pneumococcal vaccine era. JAMA Otolaryngol Head Neck Surg. 2013; 139(3): 223–27.

https://doi.org/10.1001/jamaoto.2013.1703. PMID: 23429877.

29. Дик Е.В. Внутричерепные осложнения воспалительных заболеваний носа. Вестник хирургии Казахстана. 2011; (4): 114–116. (Dick E.V. Intracranial complications of inflammatory diseases of the nose. Vestnik khirurgii Kazakhstana = Bulletin of Surgery of Kazakhstan. 2011; (4): 114–116 (In Russ.)).

30. Байтяков В.В., Константинидис К. Частота орбитальных осложнений острого гнойного синусита. Огарев-Online. 2017; (7): 5. (Baityakov V.V., Konstantinidis K. The frequency of orbital complications of acute purulent sinusitis. Ogaryov-Online. 2017; (7): 5 (In Russ.)). EDN: ZOLDZB.

31. Чучалин А.Г., Брико Н.И., Авдеев С.Н. с соавт. Федеральные клинические рекомендации по вакцинопрофилактике пневмококковой инфекции у взрослых. Пульмонология. 2019; 29(1): 19–34. (Chuchalin A.G., Briko N.I., Avdeev S.N. et al. Federal clinical guidelines on preventive vaccination against pneumococcal infections in adults. Pul’monologiya = Pulmonology. 2019; 29(1): 19–34 (In Russ.)).

https://doi.org/10.18093/0869-0189-2019-29-1-19-34. EDN: WCBYZD.

32. Pletz M.W., Maus U., Krug N. et al. Pneumococcal vaccines: Mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents. 2008; 32(3): 199–206.

https://doi.org/10.1016/j.ijantimicag.2008.01.021. PMID: 18378430.

33. Драпкина О.М., Брико Н.И., Костинов М.П. с соавт. Иммунизация взрослых. Методические рекомендации. М.: ФГБУ «НМИЦ ТПМ» Минздрава России. 2020; 248 с. (Drapkina O.M., Briko N.I., Kostinov M.P. et al. Immunization of adults. Methodical recommendations. Moscow: National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthсare of Russia. 2020; 248 pp. (In Russ.)). ISBN: 978-5-6043991-3-2.

34. Miller E., Andrews N.J., Waight P.A. et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: An observational cohort study. Lancet Infect Dis. 2011; 11(10): 760–68.

https://doi.org/10.1016/s1473-3099(11)70090-1. PMID: 21621466.

35. Moore M.R., Gertz R.E. Jr., Woodbury R.L. et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis. 2008; 197(7): 1016–27.

https://doi.org/10.1086/528996. PMID: 18419539.

36. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003. MMWR Morb Mortal Wkly Rep. 2005; 54(36): 893–97. PMID: 16163262.

37. Grijalva C.G., Poehling K.A., Nuorti J.P. et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006; 118(3): 865–73.

https://doi.org/10.1542/peds.2006-0492. PMID: 16950975.

38. National Vaccine Advisory Committee. A call for greater consideration for the role of vaccines in national strategies to combat antibiotic-resistant bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015. Public Health Rep. 2016; 131(1): 11–16. PMID: 26843664. PMCID: PMC4716466.

39. von Gottberg A., de Gouveia L., Tempia S. et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371(20): 1889–99.

https://doi.org/10.1056/nejmoa1401914. PMID: 25386897.

40. Webber C., Patton M., Patterson S. et al. Exploratory efficacy endpoints in the Community − Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Vaccine. 2017; 35(9): 1266–72.

https://doi.org/10.1016/j.vaccine.2017.01.032. PMID: 28173960.

41. Bonten M.J.M., Huijts S.M., Bolkenbaas M. et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015; 372(12): 1114–25.

https://doi.org/10.1056/nejmoa1408544. PMID: 25785969.

42. Kolditz M., Schmitt J., Pletz M.W., Tesch F. Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged ≥ 60 years: A population-based retrospective cohort study. Clin Infect Dis. 2019; 68(12): 2117–19.

https://doi.org/10.1093/cid/ciy993. PMID: 30462172.

43. Рудакова А.В., Брико Н.И., Лобзин Ю.В. с соавт. Вакцинация взрослых против пневмококковой инфекции в Российской Федерации: социальные и фармакоэкономические аспекты. Журнал инфектологии. 2018; 10(3): 11–22. (Rudakova A.V., Briko N.I., Lobzin Yu.V. et al. Vaccination against pneumococcal infections in Russian Federation: Social and pharmacoeconomic aspects. Zhurnal infektologii = Journal Infectology. 2018; 10(3): 11–22 (In Russ.)).

https://doi.org/10.22625/2072-6732-2018-10-3-11-22. EDN: YOQYXB.

44. Walters J.A., Tang J.N.Q., Poole P., Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017; 1(1): CD001390.

https://doi.org/10.1002/14651858.CD001390.pub4. PMID: 28116747. PMCID: PMC6422320.

45. Игнатова Г.Л., Антонов В.Н. Эпидемиологические особенности хронической респираторной патологии при вакцинации против пневмококковой инфекции. Пульмонология. 2017; 27(3): 376–383. (Ignatova G.L., Antonov V.N. Epidemiological characteristics of chronic respiratory diseases in patients vaccinated against pneumococcal infection. Pul’monologiya = Pulmonology. 2017; 27(3): 376–383 (In Russ.)).

https://doi.org/10.18093/0869-0189-2017-27-3-376-383. EDN: ZEKPWX.

46. Игнатова Г.Л., Авдеев С.Н., Антонов В.Н., Блинова Е.В. Десятилетний анализ эффективности вакцинации против пневмококковой инфекции у пациентов с хронической обструктивной болезнью легких. Пульмонология. 2023; 33(6): 750–758. (Ignatova G.L., Avdeev S.N., Antonov V.N., Blinova E.V. Ten-year analysis of the efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease. Pul’monologiya = Pulmonology. 2023; 33(6): 750–758 (In Russ.)).

https://doi.org/10.18093/0869-0189-2023-33-6-750-758. EDN: KUKQRY.